SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-06-000177
Filing Date
2006-02-13
Accepted
2006-02-10 17:43:53
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 bvf-neuro_sc13g.htm SC 13G/A 103040
  Complete submission text file 0000898432-06-000177.txt   105274
Mailing Address 1387 MARINA WAY SOUTH RICHMOND CA 94804
Business Address 1387 MARINA WAY S RICHMOND CA 94804 5102158000
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (Subject) CIK: 0000918112 (see all company filings)

IRS No.: 943049219 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-49135 | Film No.: 06600062
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice